Plant-Based Dietary Intervention in Type 2 Diabetes-2
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: Low-fat, low-Glycemic Index, vegan dietBehavioral: ADA diet
- Registration Number
- NCT01931631
- Lead Sponsor
- Physicians Committee for Responsible Medicine
- Brief Summary
The purpose of the study is to assess whether, in individuals with type 2 diabetes, a low-fat, vegan diet improves blood glucose control more effectively than a control diet based on current American Diabetes Association (ADA) guidelines. The principal measure is hemoglobin A1c. Cardiovascular risk factors and dietary acceptability are also assessed. The study duration is 20 weeks with a one-year follow-up.
- Detailed Description
Preliminary evidence suggests that low-fat, vegetarian regimens similar to those used to reverse coronary artery blockages may have a significant beneficial effect on type 2 diabetes, as demonstrated by reductions in fasting serum glucose concentrations and medication use. The investigators therefore randomly assigned 99 individuals with type 2 diabetes to either a low-fat, vegan diet or a diet based on current American Diabetes Association guidelines for 22 weeks with a one-year follow-up period. The principal dependent measure is hemoglobin A1c. Cardiovascular risk factors are also being tracked, as is dietary acceptance.
Recruitment & Eligibility
- Status
- SUSPENDED
- Sex
- All
- Target Recruitment
- 60
- Diagnosis of Type 2 Diabetes Mellitus
- hemoglobin A1c values <6.5% or >10.5% use of insulin for > 5 years tobacco use within the preceding 6 months consumption of more than 2 alcoholic beverages per day current drug abuse pregnancy unstable medical status current use of a low-fat, vegetarian diet.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low-fat, low-Glycemic Index, vegan diet Low-fat, low-Glycemic Index, vegan diet Low-fat, low-Glycemic Index, vegan diet ADA diet ADA diet American Diabetes Association diet
- Primary Outcome Measures
Name Time Method Hemoglobin A1c 20 weeks
- Secondary Outcome Measures
Name Time Method Blood Pressure 20 Weeks International Physical Activity Questionnaire 20 Weeks Comprehensive Metabolic Panel 20 Weeks & one-year follow up Urinary albumin and creatinine 20 Weeks Waist and hip circumference 20 Weeks Dietary Acceptability 20 Weeks Food Acceptability Questionnaire 20 Weeks CESD-R (Center for Epidemiologic Studies Depression Scale: Review and revision) 20 Weeks Body Weight 20 Weeks Glucose 20 Weeks Eating Inventory 20 Weeks Beck Depression Inventory II (BDI-II) 20 Weeks Serum cholesterol and triacylglycerol concentrations 20 Weeks 3-day dietary records 20 Weeks Genotyping for Taq1 A and Taq1 B polymorphisms, and APOE (Apolipoprotein E) 20 Weeks
Trial Locations
- Locations (1)
Physicians Committee for Responsible Medicine
🇺🇸Washington, District of Columbia, United States